HomeSYRE • NASDAQ
add
Spyre Therapeutics Inc
Previous close
$18.92
Year range
$10.91 - $40.26
Market cap
1.14B USD
Avg Volume
729.27K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 11.79M | 2.42% |
Net income | -36.72M | 5.46% |
Net profit margin | — | — |
Earnings per share | -0.49 | 43.02% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 526.58M | 23.61% |
Total assets | 538.83M | 23.57% |
Total liabilities | 83.06M | 34.66% |
Total equity | 455.77M | — |
Shares outstanding | 60.40M | — |
Price to book | 3.81 | — |
Return on assets | -23.42% | — |
Return on capital | -27.67% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -36.72M | 5.46% |
Cash from operations | -46.56M | 25.20% |
Cash from investing | 79.00M | 165.55% |
Cash from financing | 731.00K | 103.06% |
Net change in cash | 33.17M | 118.18% |
Free cash flow | -18.00M | 61.46% |
About
Founded
Jan 1, 2013
Headquarters
Website
Employees
87
